nodes	percent_of_prediction	percent_of_DWPC	metapath
Amiloride—AOC1—embryo—liver cancer	0.00452	0.235	CbGeAlD
Amiloride—Gynaecomastia—Sorafenib—liver cancer	0.00435	0.0258	CcSEcCtD
Amiloride—SLC9A1—embryo—liver cancer	0.00433	0.225	CbGeAlD
Amiloride—Hepatic function abnormal—Sorafenib—liver cancer	0.00404	0.024	CcSEcCtD
Amiloride—Hyponatraemia—Sorafenib—liver cancer	0.00355	0.021	CcSEcCtD
Amiloride—Pain in extremity—Sorafenib—liver cancer	0.00353	0.021	CcSEcCtD
Amiloride—Neutropenia—Sorafenib—liver cancer	0.00286	0.0169	CcSEcCtD
Amiloride—Erectile dysfunction—Sorafenib—liver cancer	0.00281	0.0167	CcSEcCtD
Amiloride—Jaundice—Sorafenib—liver cancer	0.00265	0.0157	CcSEcCtD
Amiloride—Haemoglobin—Sorafenib—liver cancer	0.00246	0.0146	CcSEcCtD
Amiloride—Haemorrhage—Sorafenib—liver cancer	0.00244	0.0145	CcSEcCtD
Amiloride—Tinnitus—Sorafenib—liver cancer	0.00228	0.0135	CcSEcCtD
Amiloride—Alopecia—Sorafenib—liver cancer	0.00216	0.0128	CcSEcCtD
Amiloride—SCNN1D—liver—liver cancer	0.00213	0.111	CbGeAlD
Amiloride—AOC1—liver—liver cancer	0.00209	0.108	CbGeAlD
Amiloride—Muscle spasms—Sorafenib—liver cancer	0.00205	0.0121	CcSEcCtD
Amiloride—SLC9A1—liver—liver cancer	0.002	0.104	CbGeAlD
Amiloride—Hyperuricaemia—Epirubicin—liver cancer	0.00194	0.0115	CcSEcCtD
Amiloride—PLAU—liver—liver cancer	0.0019	0.0985	CbGeAlD
Amiloride—Cough—Sorafenib—liver cancer	0.00186	0.011	CcSEcCtD
Amiloride—Blood uric acid increased—Epirubicin—liver cancer	0.00183	0.0109	CcSEcCtD
Amiloride—Neck pain—Epirubicin—liver cancer	0.00182	0.0108	CcSEcCtD
Amiloride—Arthralgia—Sorafenib—liver cancer	0.00181	0.0107	CcSEcCtD
Amiloride—Hepatocellular injury—Epirubicin—liver cancer	0.0018	0.0107	CcSEcCtD
Amiloride—Hyperuricaemia—Doxorubicin—liver cancer	0.00179	0.0106	CcSEcCtD
Amiloride—Hyperkalaemia—Epirubicin—liver cancer	0.00177	0.0105	CcSEcCtD
Amiloride—Shock—Sorafenib—liver cancer	0.00171	0.0101	CcSEcCtD
Amiloride—Blood uric acid increased—Doxorubicin—liver cancer	0.00169	0.0101	CcSEcCtD
Amiloride—Aplastic anaemia—Epirubicin—liver cancer	0.00169	0.01	CcSEcCtD
Amiloride—Neck pain—Doxorubicin—liver cancer	0.00168	0.00999	CcSEcCtD
Amiloride—Hepatocellular injury—Doxorubicin—liver cancer	0.00166	0.00987	CcSEcCtD
Amiloride—SCNN1A—liver—liver cancer	0.00166	0.0863	CbGeAlD
Amiloride—Anorexia—Sorafenib—liver cancer	0.00166	0.00982	CcSEcCtD
Amiloride—Coma—Epirubicin—liver cancer	0.00164	0.00975	CcSEcCtD
Amiloride—Hyperkalaemia—Doxorubicin—liver cancer	0.00164	0.0097	CcSEcCtD
Amiloride—Musculoskeletal discomfort—Sorafenib—liver cancer	0.00158	0.00939	CcSEcCtD
Amiloride—Aplastic anaemia—Doxorubicin—liver cancer	0.00156	0.00927	CcSEcCtD
Amiloride—Dyspnoea—Sorafenib—liver cancer	0.00155	0.00918	CcSEcCtD
Amiloride—Dyspepsia—Sorafenib—liver cancer	0.00153	0.00907	CcSEcCtD
Amiloride—Coma—Doxorubicin—liver cancer	0.00152	0.00902	CcSEcCtD
Amiloride—Decreased appetite—Sorafenib—liver cancer	0.00151	0.00896	CcSEcCtD
Amiloride—Gastrointestinal disorder—Sorafenib—liver cancer	0.0015	0.00889	CcSEcCtD
Amiloride—Fatigue—Sorafenib—liver cancer	0.0015	0.00888	CcSEcCtD
Amiloride—Hepatic function abnormal—Epirubicin—liver cancer	0.00149	0.00886	CcSEcCtD
Amiloride—Constipation—Sorafenib—liver cancer	0.00148	0.00881	CcSEcCtD
Amiloride—Pain—Sorafenib—liver cancer	0.00148	0.00881	CcSEcCtD
Amiloride—Gastrointestinal pain—Sorafenib—liver cancer	0.00142	0.00842	CcSEcCtD
Amiloride—Hepatic function abnormal—Doxorubicin—liver cancer	0.00138	0.0082	CcSEcCtD
Amiloride—Abdominal pain—Sorafenib—liver cancer	0.00137	0.00814	CcSEcCtD
Amiloride—Hyponatraemia—Epirubicin—liver cancer	0.00131	0.00778	CcSEcCtD
Amiloride—Pain in extremity—Epirubicin—liver cancer	0.00131	0.00775	CcSEcCtD
Amiloride—Gastrointestinal haemorrhage—Epirubicin—liver cancer	0.00131	0.00775	CcSEcCtD
Amiloride—Asthenia—Sorafenib—liver cancer	0.00125	0.00739	CcSEcCtD
Amiloride—Pruritus—Sorafenib—liver cancer	0.00123	0.00729	CcSEcCtD
Amiloride—Hyponatraemia—Doxorubicin—liver cancer	0.00121	0.0072	CcSEcCtD
Amiloride—Gastrointestinal haemorrhage—Doxorubicin—liver cancer	0.00121	0.00717	CcSEcCtD
Amiloride—Pain in extremity—Doxorubicin—liver cancer	0.00121	0.00717	CcSEcCtD
Amiloride—Orthostatic hypotension—Epirubicin—liver cancer	0.00119	0.00707	CcSEcCtD
Amiloride—Diarrhoea—Sorafenib—liver cancer	0.00119	0.00705	CcSEcCtD
Amiloride—Muscular weakness—Epirubicin—liver cancer	0.00115	0.00683	CcSEcCtD
Amiloride—Dizziness—Sorafenib—liver cancer	0.00115	0.00681	CcSEcCtD
Amiloride—Abdominal distension—Epirubicin—liver cancer	0.00114	0.00674	CcSEcCtD
Amiloride—Vomiting—Sorafenib—liver cancer	0.0011	0.00655	CcSEcCtD
Amiloride—Orthostatic hypotension—Doxorubicin—liver cancer	0.0011	0.00655	CcSEcCtD
Amiloride—Angina pectoris—Epirubicin—liver cancer	0.0011	0.00652	CcSEcCtD
Amiloride—Rash—Sorafenib—liver cancer	0.00109	0.0065	CcSEcCtD
Amiloride—Dermatitis—Sorafenib—liver cancer	0.00109	0.00649	CcSEcCtD
Amiloride—Headache—Sorafenib—liver cancer	0.00109	0.00645	CcSEcCtD
Amiloride—Muscular weakness—Doxorubicin—liver cancer	0.00107	0.00632	CcSEcCtD
Amiloride—Neutropenia—Epirubicin—liver cancer	0.00106	0.00626	CcSEcCtD
Amiloride—Dysuria—Epirubicin—liver cancer	0.00106	0.00626	CcSEcCtD
Amiloride—Abdominal distension—Doxorubicin—liver cancer	0.00105	0.00624	CcSEcCtD
Amiloride—Pollakiuria—Epirubicin—liver cancer	0.00104	0.00618	CcSEcCtD
Amiloride—Nausea—Sorafenib—liver cancer	0.00103	0.00612	CcSEcCtD
Amiloride—Angina pectoris—Doxorubicin—liver cancer	0.00102	0.00603	CcSEcCtD
Amiloride—Jaundice—Epirubicin—liver cancer	0.000981	0.00582	CcSEcCtD
Amiloride—Dysuria—Doxorubicin—liver cancer	0.000976	0.00579	CcSEcCtD
Amiloride—Neutropenia—Doxorubicin—liver cancer	0.000976	0.00579	CcSEcCtD
Amiloride—Pollakiuria—Doxorubicin—liver cancer	0.000965	0.00572	CcSEcCtD
Amiloride—Bradycardia—Epirubicin—liver cancer	0.00092	0.00546	CcSEcCtD
Amiloride—Haemoglobin—Epirubicin—liver cancer	0.000908	0.00539	CcSEcCtD
Amiloride—Jaundice—Doxorubicin—liver cancer	0.000908	0.00538	CcSEcCtD
Amiloride—Haemorrhage—Epirubicin—liver cancer	0.000903	0.00536	CcSEcCtD
Amiloride—Visual impairment—Epirubicin—liver cancer	0.000871	0.00516	CcSEcCtD
Amiloride—Bradycardia—Doxorubicin—liver cancer	0.000851	0.00505	CcSEcCtD
Amiloride—Tinnitus—Epirubicin—liver cancer	0.000842	0.005	CcSEcCtD
Amiloride—Haemoglobin—Doxorubicin—liver cancer	0.00084	0.00498	CcSEcCtD
Amiloride—Haemorrhage—Doxorubicin—liver cancer	0.000836	0.00496	CcSEcCtD
Amiloride—Visual impairment—Doxorubicin—liver cancer	0.000805	0.00478	CcSEcCtD
Amiloride—Alopecia—Epirubicin—liver cancer	0.000798	0.00474	CcSEcCtD
Amiloride—Tinnitus—Doxorubicin—liver cancer	0.000779	0.00462	CcSEcCtD
Amiloride—Flatulence—Epirubicin—liver cancer	0.000775	0.0046	CcSEcCtD
Amiloride—Tension—Epirubicin—liver cancer	0.000772	0.00458	CcSEcCtD
Amiloride—Nervousness—Epirubicin—liver cancer	0.000764	0.00453	CcSEcCtD
Amiloride—Back pain—Epirubicin—liver cancer	0.000761	0.00451	CcSEcCtD
Amiloride—Muscle spasms—Epirubicin—liver cancer	0.000756	0.00448	CcSEcCtD
Amiloride—Alopecia—Doxorubicin—liver cancer	0.000739	0.00438	CcSEcCtD
Amiloride—Flatulence—Doxorubicin—liver cancer	0.000717	0.00425	CcSEcCtD
Amiloride—Tension—Doxorubicin—liver cancer	0.000714	0.00424	CcSEcCtD
Amiloride—SLC9A1—ErbB1 downstream signaling—KRAS—liver cancer	0.000713	0.000877	CbGpPWpGaD
Amiloride—PLAU—Wnt Signaling Pathway and Pluripotency—MYC—liver cancer	0.000712	0.000877	CbGpPWpGaD
Amiloride—Nervousness—Doxorubicin—liver cancer	0.000707	0.00419	CcSEcCtD
Amiloride—Vertigo—Epirubicin—liver cancer	0.000706	0.00419	CcSEcCtD
Amiloride—Back pain—Doxorubicin—liver cancer	0.000704	0.00418	CcSEcCtD
Amiloride—Muscle spasms—Doxorubicin—liver cancer	0.0007	0.00415	CcSEcCtD
Amiloride—Palpitations—Epirubicin—liver cancer	0.000695	0.00412	CcSEcCtD
Amiloride—PLAU—Senescence and Autophagy in Cancer—TGFB1—liver cancer	0.000694	0.000854	CbGpPWpGaD
Amiloride—Cough—Epirubicin—liver cancer	0.000686	0.00407	CcSEcCtD
Amiloride—PLAU—DNA Damage Response (only ATM dependent)—MYC—liver cancer	0.000675	0.000831	CbGpPWpGaD
Amiloride—PLAU—DNA Damage Response (only ATM dependent)—TGFB1—liver cancer	0.000674	0.000829	CbGpPWpGaD
Amiloride—Chest pain—Epirubicin—liver cancer	0.000669	0.00397	CcSEcCtD
Amiloride—Arthralgia—Epirubicin—liver cancer	0.000669	0.00397	CcSEcCtD
Amiloride—SLC9A1—G Protein Signaling Pathways—HRAS—liver cancer	0.000667	0.000822	CbGpPWpGaD
Amiloride—SLC9A1—ErbB1 downstream signaling—PIK3CA—liver cancer	0.000655	0.000806	CbGpPWpGaD
Amiloride—Vertigo—Doxorubicin—liver cancer	0.000654	0.00388	CcSEcCtD
Amiloride—SLC9A1—Disease—LTF—liver cancer	0.000652	0.000803	CbGpPWpGaD
Amiloride—Confusional state—Epirubicin—liver cancer	0.000647	0.00384	CcSEcCtD
Amiloride—Palpitations—Doxorubicin—liver cancer	0.000643	0.00381	CcSEcCtD
Amiloride—Cough—Doxorubicin—liver cancer	0.000635	0.00377	CcSEcCtD
Amiloride—SLC22A1—liver—liver cancer	0.000634	0.0329	CbGeAlD
Amiloride—Shock—Epirubicin—liver cancer	0.000631	0.00375	CcSEcCtD
Amiloride—PLAU—DNA Damage Response (only ATM dependent)—KRAS—liver cancer	0.000624	0.000768	CbGpPWpGaD
Amiloride—Arthralgia—Doxorubicin—liver cancer	0.000619	0.00367	CcSEcCtD
Amiloride—Chest pain—Doxorubicin—liver cancer	0.000619	0.00367	CcSEcCtD
Amiloride—SLC22A2—Transmission across Chemical Synapses—GLUL—liver cancer	0.000613	0.000755	CbGpPWpGaD
Amiloride—Anorexia—Epirubicin—liver cancer	0.000612	0.00363	CcSEcCtD
Amiloride—PLAU—Hemostasis—IFNA1—liver cancer	0.000611	0.000753	CbGpPWpGaD
Amiloride—SCNN1D—Transmembrane transport of small molecules—PPARA—liver cancer	0.000611	0.000752	CbGpPWpGaD
Amiloride—SCNN1A—Transmembrane transport of small molecules—PPARA—liver cancer	0.000611	0.000752	CbGpPWpGaD
Amiloride—ASIC1—Transmembrane transport of small molecules—PPARA—liver cancer	0.000611	0.000752	CbGpPWpGaD
Amiloride—SCNN1B—Transmembrane transport of small molecules—PPARA—liver cancer	0.000611	0.000752	CbGpPWpGaD
Amiloride—SCNN1G—Transmembrane transport of small molecules—PPARA—liver cancer	0.000611	0.000752	CbGpPWpGaD
Amiloride—SLC9A1—ErbB1 downstream signaling—HRAS—liver cancer	0.000606	0.000746	CbGpPWpGaD
Amiloride—ASIC2—Transmembrane transport of small molecules—ALB—liver cancer	0.000599	0.000737	CbGpPWpGaD
Amiloride—Confusional state—Doxorubicin—liver cancer	0.000599	0.00355	CcSEcCtD
Amiloride—SLC22A4—Transmembrane transport of small molecules—SLC11A2—liver cancer	0.000595	0.000733	CbGpPWpGaD
Amiloride—SLC9A1—SLC-mediated transmembrane transport—ALB—liver cancer	0.000589	0.000725	CbGpPWpGaD
Amiloride—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000585	0.00347	CcSEcCtD
Amiloride—PLAU—Wnt Signaling Pathway and Pluripotency—TP53—liver cancer	0.000585	0.00072	CbGpPWpGaD
Amiloride—Shock—Doxorubicin—liver cancer	0.000584	0.00347	CcSEcCtD
Amiloride—Insomnia—Epirubicin—liver cancer	0.00058	0.00344	CcSEcCtD
Amiloride—Paraesthesia—Epirubicin—liver cancer	0.000576	0.00342	CcSEcCtD
Amiloride—SLC9A1—Transmembrane transport of small molecules—CYCS—liver cancer	0.000573	0.000706	CbGpPWpGaD
Amiloride—PLAU—DNA Damage Response (only ATM dependent)—PIK3CA—liver cancer	0.000573	0.000706	CbGpPWpGaD
Amiloride—Dyspnoea—Epirubicin—liver cancer	0.000572	0.00339	CcSEcCtD
Amiloride—PLAU—Senescence and Autophagy in Cancer—TP53—liver cancer	0.000571	0.000703	CbGpPWpGaD
Amiloride—SLC22A1—Transmission across Chemical Synapses—GLUL—liver cancer	0.000571	0.000703	CbGpPWpGaD
Amiloride—Somnolence—Epirubicin—liver cancer	0.000571	0.00338	CcSEcCtD
Amiloride—SLC22A4—Transmembrane transport of small molecules—SLC40A1—liver cancer	0.000568	0.000699	CbGpPWpGaD
Amiloride—Anorexia—Doxorubicin—liver cancer	0.000566	0.00336	CcSEcCtD
Amiloride—Dyspepsia—Epirubicin—liver cancer	0.000565	0.00335	CcSEcCtD
Amiloride—Decreased appetite—Epirubicin—liver cancer	0.000558	0.00331	CcSEcCtD
Amiloride—PLAU—DNA Damage Response (only ATM dependent)—TP53—liver cancer	0.000554	0.000683	CbGpPWpGaD
Amiloride—Gastrointestinal disorder—Epirubicin—liver cancer	0.000554	0.00329	CcSEcCtD
Amiloride—SLC22A2—SLC-mediated transmembrane transport—SLC11A2—liver cancer	0.000554	0.000682	CbGpPWpGaD
Amiloride—Fatigue—Epirubicin—liver cancer	0.000553	0.00328	CcSEcCtD
Amiloride—SLC22A2—Transmembrane transport of small molecules—SLC9C1—liver cancer	0.00055	0.000677	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—MYO5B—liver cancer	0.00055	0.000677	CbGpPWpGaD
Amiloride—Constipation—Epirubicin—liver cancer	0.000549	0.00326	CcSEcCtD
Amiloride—Pain—Epirubicin—liver cancer	0.000549	0.00326	CcSEcCtD
Amiloride—PLAU—Senescence and Autophagy in Cancer—HRAS—liver cancer	0.000546	0.000673	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—CPT1B—liver cancer	0.000546	0.000673	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—GLUL—liver cancer	0.000546	0.000673	CbGpPWpGaD
Amiloride—SLC22A4—Transmembrane transport of small molecules—ANXA2—liver cancer	0.000544	0.00067	CbGpPWpGaD
Amiloride—SLC22A4—Transmembrane transport of small molecules—ATP7B—liver cancer	0.000544	0.00067	CbGpPWpGaD
Amiloride—ASIC2—Transmembrane transport of small molecules—RAF1—liver cancer	0.000542	0.000667	CbGpPWpGaD
Amiloride—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.000541	0.00321	CcSEcCtD
Amiloride—PLAU—Hemostasis—PRKCE—liver cancer	0.000541	0.000666	CbGpPWpGaD
Amiloride—SLC9A1—Regulation of Actin Cytoskeleton—KRAS—liver cancer	0.000539	0.000663	CbGpPWpGaD
Amiloride—Insomnia—Doxorubicin—liver cancer	0.000537	0.00319	CcSEcCtD
Amiloride—SLC9A1—ErbB1 downstream signaling—AKT1—liver cancer	0.000535	0.000658	CbGpPWpGaD
Amiloride—Paraesthesia—Doxorubicin—liver cancer	0.000533	0.00316	CcSEcCtD
Amiloride—PLAU—DNA Damage Response (only ATM dependent)—HRAS—liver cancer	0.00053	0.000653	CbGpPWpGaD
Amiloride—Dyspnoea—Doxorubicin—liver cancer	0.000529	0.00314	CcSEcCtD
Amiloride—Feeling abnormal—Epirubicin—liver cancer	0.000529	0.00314	CcSEcCtD
Amiloride—SLC22A2—SLC-mediated transmembrane transport—SLC40A1—liver cancer	0.000528	0.000651	CbGpPWpGaD
Amiloride—Somnolence—Doxorubicin—liver cancer	0.000528	0.00313	CcSEcCtD
Amiloride—SLC9A1—Metabolism—NR1H4—liver cancer	0.000527	0.000649	CbGpPWpGaD
Amiloride—Gastrointestinal pain—Epirubicin—liver cancer	0.000525	0.00311	CcSEcCtD
Amiloride—PLAU—Senescence and Autophagy in Cancer—IL6—liver cancer	0.000523	0.000644	CbGpPWpGaD
Amiloride—Dyspepsia—Doxorubicin—liver cancer	0.000523	0.0031	CcSEcCtD
Amiloride—SLC9A1—Metabolism—GSTA3—liver cancer	0.000518	0.000638	CbGpPWpGaD
Amiloride—SLC22A1—SLC-mediated transmembrane transport—SLC11A2—liver cancer	0.000516	0.000636	CbGpPWpGaD
Amiloride—Decreased appetite—Doxorubicin—liver cancer	0.000516	0.00306	CcSEcCtD
Amiloride—SLC22A4—Transmembrane transport of small molecules—NR1H4—liver cancer	0.000515	0.000634	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—ABL1—liver cancer	0.000515	0.000634	CbGpPWpGaD
Amiloride—Gastrointestinal disorder—Doxorubicin—liver cancer	0.000513	0.00304	CcSEcCtD
Amiloride—SLC22A1—Transmembrane transport of small molecules—SLC9C1—liver cancer	0.000513	0.000631	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—MYO5B—liver cancer	0.000513	0.000631	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—IGF2—liver cancer	0.000512	0.000631	CbGpPWpGaD
Amiloride—Fatigue—Doxorubicin—liver cancer	0.000512	0.00304	CcSEcCtD
Amiloride—Constipation—Doxorubicin—liver cancer	0.000508	0.00301	CcSEcCtD
Amiloride—Pain—Doxorubicin—liver cancer	0.000508	0.00301	CcSEcCtD
Amiloride—Abdominal pain—Epirubicin—liver cancer	0.000507	0.00301	CcSEcCtD
Amiloride—SLC9A1—Disease—ALDOB—liver cancer	0.000504	0.000621	CbGpPWpGaD
Amiloride—SLC9A1—Transmembrane transport of small molecules—HMOX1—liver cancer	0.000498	0.000614	CbGpPWpGaD
Amiloride—SLC9A1—Regulation of Actin Cytoskeleton—PIK3CA—liver cancer	0.000495	0.000609	CbGpPWpGaD
Amiloride—SLC22A1—SLC-mediated transmembrane transport—SLC40A1—liver cancer	0.000493	0.000606	CbGpPWpGaD
Amiloride—Feeling abnormal—Doxorubicin—liver cancer	0.000489	0.0029	CcSEcCtD
Amiloride—Gastrointestinal pain—Doxorubicin—liver cancer	0.000486	0.00288	CcSEcCtD
Amiloride—PLAU—Hemostasis—HGF—liver cancer	0.000484	0.000596	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—CSF2—liver cancer	0.000478	0.000589	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—GSTA4—liver cancer	0.000474	0.000583	CbGpPWpGaD
Amiloride—SLC22A2—Neuronal System—GLUL—liver cancer	0.00047	0.000578	CbGpPWpGaD
Amiloride—Abdominal pain—Doxorubicin—liver cancer	0.000469	0.00278	CcSEcCtD
Amiloride—PLAU—DNA Damage Response (only ATM dependent)—AKT1—liver cancer	0.000468	0.000576	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—GSTA2—liver cancer	0.000462	0.000568	CbGpPWpGaD
Amiloride—Asthenia—Epirubicin—liver cancer	0.00046	0.00273	CcSEcCtD
Amiloride—Pruritus—Epirubicin—liver cancer	0.000454	0.00269	CcSEcCtD
Amiloride—SCNN1A—Transmembrane transport of small molecules—ALB—liver cancer	0.000454	0.000559	CbGpPWpGaD
Amiloride—SCNN1G—Transmembrane transport of small molecules—ALB—liver cancer	0.000454	0.000559	CbGpPWpGaD
Amiloride—ASIC1—Transmembrane transport of small molecules—ALB—liver cancer	0.000454	0.000559	CbGpPWpGaD
Amiloride—SCNN1D—Transmembrane transport of small molecules—ALB—liver cancer	0.000454	0.000559	CbGpPWpGaD
Amiloride—SCNN1B—Transmembrane transport of small molecules—ALB—liver cancer	0.000454	0.000559	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—GSTA1—liver cancer	0.000445	0.000548	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—NAT2—liver cancer	0.00044	0.000542	CbGpPWpGaD
Amiloride—Diarrhoea—Epirubicin—liver cancer	0.000439	0.0026	CcSEcCtD
Amiloride—SLC22A1—Neuronal System—GLUL—liver cancer	0.000438	0.000539	CbGpPWpGaD
Amiloride—Asthenia—Doxorubicin—liver cancer	0.000426	0.00253	CcSEcCtD
Amiloride—Dizziness—Epirubicin—liver cancer	0.000424	0.00252	CcSEcCtD
Amiloride—SLC9A1—Metabolism—ALDOB—liver cancer	0.000422	0.00052	CbGpPWpGaD
Amiloride—Pruritus—Doxorubicin—liver cancer	0.00042	0.00249	CcSEcCtD
Amiloride—SCNN1G—Transmembrane transport of small molecules—RAF1—liver cancer	0.00041	0.000505	CbGpPWpGaD
Amiloride—ASIC1—Transmembrane transport of small molecules—RAF1—liver cancer	0.00041	0.000505	CbGpPWpGaD
Amiloride—SCNN1A—Transmembrane transport of small molecules—RAF1—liver cancer	0.00041	0.000505	CbGpPWpGaD
Amiloride—SCNN1B—Transmembrane transport of small molecules—RAF1—liver cancer	0.00041	0.000505	CbGpPWpGaD
Amiloride—SCNN1D—Transmembrane transport of small molecules—RAF1—liver cancer	0.00041	0.000505	CbGpPWpGaD
Amiloride—Vomiting—Epirubicin—liver cancer	0.000408	0.00242	CcSEcCtD
Amiloride—Diarrhoea—Doxorubicin—liver cancer	0.000406	0.00241	CcSEcCtD
Amiloride—Rash—Epirubicin—liver cancer	0.000405	0.0024	CcSEcCtD
Amiloride—Dermatitis—Epirubicin—liver cancer	0.000404	0.0024	CcSEcCtD
Amiloride—SLC9A1—Metabolism—CRABP1—liver cancer	0.000403	0.000496	CbGpPWpGaD
Amiloride—SLC9A1—Transmembrane transport of small molecules—PPARA—liver cancer	0.000403	0.000496	CbGpPWpGaD
Amiloride—Headache—Epirubicin—liver cancer	0.000402	0.00239	CcSEcCtD
Amiloride—SLC9A1—Disease—ADAM17—liver cancer	0.000399	0.000491	CbGpPWpGaD
Amiloride—Dizziness—Doxorubicin—liver cancer	0.000393	0.00233	CcSEcCtD
Amiloride—PLAU—Hemostasis—MAPK14—liver cancer	0.000387	0.000477	CbGpPWpGaD
Amiloride—Nausea—Epirubicin—liver cancer	0.000381	0.00226	CcSEcCtD
Amiloride—Vomiting—Doxorubicin—liver cancer	0.000378	0.00224	CcSEcCtD
Amiloride—PLAU—Hemostasis—F2—liver cancer	0.000375	0.000462	CbGpPWpGaD
Amiloride—SLC9A1—Disease—PSMD10—liver cancer	0.000375	0.000461	CbGpPWpGaD
Amiloride—SLC9A1—Disease—PSMA4—liver cancer	0.000375	0.000461	CbGpPWpGaD
Amiloride—Rash—Doxorubicin—liver cancer	0.000374	0.00222	CcSEcCtD
Amiloride—Dermatitis—Doxorubicin—liver cancer	0.000374	0.00222	CcSEcCtD
Amiloride—Headache—Doxorubicin—liver cancer	0.000372	0.00221	CcSEcCtD
Amiloride—SLC9A1—Disease—GOT2—liver cancer	0.000364	0.000449	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—PIK3CG—liver cancer	0.000359	0.000442	CbGpPWpGaD
Amiloride—Nausea—Doxorubicin—liver cancer	0.000353	0.00209	CcSEcCtD
Amiloride—SLC9A1—Metabolism—HPGDS—liver cancer	0.000352	0.000433	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—PIK3CD—liver cancer	0.000316	0.000389	CbGpPWpGaD
Amiloride—SLC9A1—Disease—GOT1—liver cancer	0.000315	0.000387	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—PSMD10—liver cancer	0.000314	0.000386	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—PSMA4—liver cancer	0.000314	0.000386	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—SERPINE1—liver cancer	0.000312	0.000385	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—ALB—liver cancer	0.000312	0.000384	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—GOT2—liver cancer	0.000305	0.000376	CbGpPWpGaD
Amiloride—SLC9A1—Transmembrane transport of small molecules—ALB—liver cancer	0.000299	0.000368	CbGpPWpGaD
Amiloride—SLC9A1—Disease—PRKCE—liver cancer	0.00029	0.000357	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—CYP2E1—liver cancer	0.000287	0.000353	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—RAF1—liver cancer	0.000282	0.000347	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—SLC11A2—liver cancer	0.000281	0.000347	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—PIK3CB—liver cancer	0.000275	0.000339	CbGpPWpGaD
Amiloride—SLC9A1—Transmembrane transport of small molecules—RAF1—liver cancer	0.000271	0.000333	CbGpPWpGaD
Amiloride—SLC22A4—SLC-mediated transmembrane transport—ALB—liver cancer	0.000269	0.000332	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—SLC40A1—liver cancer	0.000269	0.000331	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—CYCS—liver cancer	0.000269	0.000331	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—GGT1—liver cancer	0.000263	0.000324	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—GOT1—liver cancer	0.000263	0.000324	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—SLC11A2—liver cancer	0.000262	0.000323	CbGpPWpGaD
Amiloride—SLC22A4—Transmembrane transport of small molecules—CYCS—liver cancer	0.000262	0.000323	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—ATP7B—liver cancer	0.000257	0.000317	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—ANXA2—liver cancer	0.000257	0.000317	CbGpPWpGaD
Amiloride—SLC9A1—Disease—H2AFX—liver cancer	0.000253	0.000312	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—IL2—liver cancer	0.000253	0.000311	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—SLC40A1—liver cancer	0.00025	0.000308	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—NR1H4—liver cancer	0.000243	0.0003	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—ATP7B—liver cancer	0.00024	0.000295	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—ANXA2—liver cancer	0.00024	0.000295	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—GSTP1—liver cancer	0.000237	0.000291	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—HMOX1—liver cancer	0.000233	0.000287	CbGpPWpGaD
Amiloride—SLC9A1—Disease—MTHFR—liver cancer	0.00023	0.000283	CbGpPWpGaD
Amiloride—SLC9A1—Disease—TERT—liver cancer	0.000229	0.000282	CbGpPWpGaD
Amiloride—SLC22A4—Transmembrane transport of small molecules—HMOX1—liver cancer	0.000228	0.000281	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—NR1H4—liver cancer	0.000227	0.000279	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—GSTM1—liver cancer	0.000217	0.000268	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—VEGFA—liver cancer	0.000215	0.000265	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—CYP1A1—liver cancer	0.000206	0.000254	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—TGFB1—liver cancer	0.000197	0.000243	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—UGDH—liver cancer	0.000195	0.00024	CbGpPWpGaD
Amiloride—SLC9A1—Disease—APC—liver cancer	0.000193	0.000237	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—MTHFR—liver cancer	0.000192	0.000237	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—PPARA—liver cancer	0.000189	0.000232	CbGpPWpGaD
Amiloride—SLC22A4—Transmembrane transport of small molecules—PPARA—liver cancer	0.000184	0.000227	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—EPT1—liver cancer	0.000184	0.000226	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—KRAS—liver cancer	0.000183	0.000225	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—UGDH—liver cancer	0.000182	0.000224	CbGpPWpGaD
Amiloride—SLC9A1—Disease—BRAF—liver cancer	0.000181	0.000223	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—TAT—liver cancer	0.000174	0.000214	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—EPT1—liver cancer	0.000171	0.000211	CbGpPWpGaD
Amiloride—SLC22A2—Transmission across Chemical Synapses—BRAF—liver cancer	0.00017	0.00021	CbGpPWpGaD
Amiloride—SLC9A1—Disease—PIK3CD—liver cancer	0.00017	0.000209	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—PIK3CA—liver cancer	0.000168	0.000207	CbGpPWpGaD
Amiloride—SLC9A1—Disease—SERPINE1—liver cancer	0.000168	0.000206	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—TP53—liver cancer	0.000162	0.0002	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—TAT—liver cancer	0.000162	0.0002	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—PIK3CG—liver cancer	0.000162	0.000199	CbGpPWpGaD
Amiloride—SLC22A1—Transmission across Chemical Synapses—BRAF—liver cancer	0.000159	0.000195	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—PPARG—liver cancer	0.000156	0.000192	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—HRAS—liver cancer	0.000155	0.000191	CbGpPWpGaD
Amiloride—SLC9A1—Disease—RAF1—liver cancer	0.000151	0.000186	CbGpPWpGaD
Amiloride—SLC9A1—Disease—MTOR—liver cancer	0.000148	0.000182	CbGpPWpGaD
Amiloride—SLC9A1—Disease—PIK3CB—liver cancer	0.000148	0.000182	CbGpPWpGaD
Amiloride—SLC22A2—Transmission across Chemical Synapses—RAF1—liver cancer	0.000142	0.000175	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—PIK3CD—liver cancer	0.000142	0.000175	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—ALB—liver cancer	0.00014	0.000173	CbGpPWpGaD
Amiloride—SLC9A1—Disease—CDKN1B—liver cancer	0.000139	0.000171	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—AKT1—liver cancer	0.000137	0.000169	CbGpPWpGaD
Amiloride—SLC22A4—Transmembrane transport of small molecules—ALB—liver cancer	0.000137	0.000169	CbGpPWpGaD
Amiloride—SLC22A1—Transmission across Chemical Synapses—RAF1—liver cancer	0.000133	0.000163	CbGpPWpGaD
Amiloride—SLC9A1—Disease—CTNNB1—liver cancer	0.000131	0.000161	CbGpPWpGaD
Amiloride—SLC22A2—Neuronal System—BRAF—liver cancer	0.00013	0.000161	CbGpPWpGaD
Amiloride—SLC9A1—Disease—CDKN1A—liver cancer	0.000128	0.000158	CbGpPWpGaD
Amiloride—SLC22A2—SLC-mediated transmembrane transport—ALB—liver cancer	0.000127	0.000157	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—CYCS—liver cancer	0.000124	0.000153	CbGpPWpGaD
Amiloride—SLC22A4—Transmembrane transport of small molecules—RAF1—liver cancer	0.000124	0.000152	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—PIK3CB—liver cancer	0.000124	0.000152	CbGpPWpGaD
Amiloride—SLC22A1—Neuronal System—BRAF—liver cancer	0.000122	0.00015	CbGpPWpGaD
Amiloride—SLC22A1—SLC-mediated transmembrane transport—ALB—liver cancer	0.000119	0.000146	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—CPT1B—liver cancer	0.000118	0.000146	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—GLUL—liver cancer	0.000118	0.000146	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—CYCS—liver cancer	0.000116	0.000142	CbGpPWpGaD
Amiloride—SLC9A1—Disease—STAT3—liver cancer	0.000114	0.000141	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—NR1H4—liver cancer	0.000114	0.00014	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—GSTA3—liver cancer	0.000112	0.000138	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—CPT1B—liver cancer	0.00011	0.000136	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—GLUL—liver cancer	0.00011	0.000136	CbGpPWpGaD
Amiloride—SLC22A2—Neuronal System—RAF1—liver cancer	0.000109	0.000134	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—HMOX1—liver cancer	0.000108	0.000133	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—NR1H4—liver cancer	0.000106	0.000131	CbGpPWpGaD
Amiloride—SLC9A1—Disease—MYC—liver cancer	0.000106	0.000131	CbGpPWpGaD
Amiloride—SLC9A1—Disease—TGFB1—liver cancer	0.000106	0.00013	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—GSTA3—liver cancer	0.000104	0.000129	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—GSTA4—liver cancer	0.000103	0.000126	CbGpPWpGaD
Amiloride—SLC22A1—Neuronal System—RAF1—liver cancer	0.000102	0.000125	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—HMOX1—liver cancer	0.000101	0.000124	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—GSTA2—liver cancer	9.99e-05	0.000123	CbGpPWpGaD
Amiloride—SLC9A1—Disease—KRAS—liver cancer	9.8e-05	0.000121	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—GSTA1—liver cancer	9.64e-05	0.000119	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—GSTA4—liver cancer	9.56e-05	0.000118	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—NAT2—liver cancer	9.53e-05	0.000117	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—GSTA2—liver cancer	9.31e-05	0.000115	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—ALDOB—liver cancer	9.14e-05	0.000113	CbGpPWpGaD
Amiloride—SLC9A1—Disease—PIK3CA—liver cancer	9.01e-05	0.000111	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—GSTA1—liver cancer	8.98e-05	0.000111	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—NAT2—liver cancer	8.88e-05	0.000109	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—CRABP1—liver cancer	8.72e-05	0.000107	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—PPARA—liver cancer	8.71e-05	0.000107	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—ALDOB—liver cancer	8.52e-05	0.000105	CbGpPWpGaD
Amiloride—SLC9A1—Disease—HRAS—liver cancer	8.33e-05	0.000103	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—CRABP1—liver cancer	8.13e-05	0.0001	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—PPARA—liver cancer	8.12e-05	0.0001	CbGpPWpGaD
Amiloride—SLC9A1—Disease—IL6—liver cancer	7.98e-05	9.82e-05	CbGpPWpGaD
Amiloride—SLC22A2—Transmission across Chemical Synapses—HRAS—liver cancer	7.83e-05	9.64e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—HPGDS—liver cancer	7.62e-05	9.38e-05	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—PIK3CA—liver cancer	7.54e-05	9.29e-05	CbGpPWpGaD
Amiloride—SLC9A1—Disease—AKT1—liver cancer	7.36e-05	9.06e-05	CbGpPWpGaD
Amiloride—SLC22A1—Transmission across Chemical Synapses—HRAS—liver cancer	7.3e-05	8.99e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—HPGDS—liver cancer	7.1e-05	8.74e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—PSMD10—liver cancer	6.79e-05	8.36e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—PSMA4—liver cancer	6.79e-05	8.36e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—GOT2—liver cancer	6.61e-05	8.13e-05	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—ALB—liver cancer	6.48e-05	7.97e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—PSMD10—liver cancer	6.33e-05	7.79e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—PSMA4—liver cancer	6.33e-05	7.79e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—CYP2E1—liver cancer	6.21e-05	7.65e-05	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—AKT1—liver cancer	6.16e-05	7.59e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—GOT2—liver cancer	6.16e-05	7.58e-05	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—ALB—liver cancer	6.04e-05	7.43e-05	CbGpPWpGaD
Amiloride—SLC22A2—Neuronal System—HRAS—liver cancer	6e-05	7.39e-05	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—RAF1—liver cancer	5.86e-05	7.21e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—CYCS—liver cancer	5.81e-05	7.16e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—CYP2E1—liver cancer	5.79e-05	7.13e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—GOT1—liver cancer	5.7e-05	7.02e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—GGT1—liver cancer	5.7e-05	7.02e-05	CbGpPWpGaD
Amiloride—SLC22A1—Neuronal System—HRAS—liver cancer	5.59e-05	6.88e-05	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—RAF1—liver cancer	5.46e-05	6.72e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—CYCS—liver cancer	5.42e-05	6.67e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—GOT1—liver cancer	5.32e-05	6.54e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—GGT1—liver cancer	5.32e-05	6.54e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—GSTP1—liver cancer	5.12e-05	6.31e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—HMOX1—liver cancer	5.05e-05	6.22e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—GSTP1—liver cancer	4.77e-05	5.88e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—HMOX1—liver cancer	4.71e-05	5.8e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—GSTM1—liver cancer	4.71e-05	5.8e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—CYP1A1—liver cancer	4.46e-05	5.49e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—GSTM1—liver cancer	4.39e-05	5.4e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—MTHFR—liver cancer	4.16e-05	5.12e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—CYP1A1—liver cancer	4.16e-05	5.12e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—PPARA—liver cancer	4.08e-05	5.03e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—MTHFR—liver cancer	3.88e-05	4.77e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—PPARA—liver cancer	3.8e-05	4.68e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—PIK3CG—liver cancer	3.5e-05	4.3e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—PPARG—liver cancer	3.37e-05	4.15e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—PIK3CG—liver cancer	3.26e-05	4.01e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—PPARG—liver cancer	3.14e-05	3.87e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—PIK3CD—liver cancer	3.07e-05	3.78e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—ALB—liver cancer	3.03e-05	3.74e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—PIK3CD—liver cancer	2.86e-05	3.53e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—ALB—liver cancer	2.83e-05	3.48e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—PIK3CB—liver cancer	2.68e-05	3.3e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—PIK3CB—liver cancer	2.5e-05	3.07e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—PIK3CA—liver cancer	1.63e-05	2.01e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—PIK3CA—liver cancer	1.52e-05	1.87e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—AKT1—liver cancer	1.33e-05	1.64e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—AKT1—liver cancer	1.24e-05	1.53e-05	CbGpPWpGaD
